TY - JOUR
T1 - Genomic copy number and expression patterns in testicular germ cell tumours
AU - McIntyre, A
AU - Summersgill, B
AU - Lu, Y J
AU - Missiaglia, E
AU - Kitazawa, S
AU - Oosterhuis, J W
AU - Looijenga, L H
AU - Shipley, J
N1 - Funding Information:
We thank Hans Stoop and Ad J.M. Gillis (Department of Pathology, Erasmus MC, Rotterdam, The Netherlands) for their contribution and also Martin Pera for providing the cell line GCT27. This study was supported by Cancer Research UK.
PY - 2007/12/17
Y1 - 2007/12/17
N2 - Testicular germ cell tumours of adults and adolescents (TGCT) include seminomas (SE) and nonseminomas (NS), with spermatocytic seminomas (SSE) representing a distinct entity in older men. SE and NS have gain of 12p material in all cases, whereas SSE are associated with overrepresentation of chromosome 9. Here, we compare at the chromosomal level, copy number imbalances with global expression changes, identified by comparative expressed sequence hybridisation analyses, in seven SE, one combined tumour, seven NS and seven cell lines. Positive correlations were found consistent with copy number as a main driver of expression change, despite reported differences in methylation status in SE and NS. Analysis of chromosomal copy number and expression data could not distinguish between SE and NS, in-keeping with a similar genetic pathogenesis. However, increased expression from 4q22, 5q23.2 and 9p21 distinguished SSE from SE and NS and decreased copy number and expression from 2q36-q37 and 6q24 was a specific feature of NS-derived cell lines. Our analysis also highlights 19 regions with both copy number and expression imbalances in greater than 40% of cases. Mining available expression array data identified genes from these regions as candidates for involvement in TGCT development. Supplementary data is available at http://www.crukdmf.icr.ac.uk/array/array.html.
AB - Testicular germ cell tumours of adults and adolescents (TGCT) include seminomas (SE) and nonseminomas (NS), with spermatocytic seminomas (SSE) representing a distinct entity in older men. SE and NS have gain of 12p material in all cases, whereas SSE are associated with overrepresentation of chromosome 9. Here, we compare at the chromosomal level, copy number imbalances with global expression changes, identified by comparative expressed sequence hybridisation analyses, in seven SE, one combined tumour, seven NS and seven cell lines. Positive correlations were found consistent with copy number as a main driver of expression change, despite reported differences in methylation status in SE and NS. Analysis of chromosomal copy number and expression data could not distinguish between SE and NS, in-keeping with a similar genetic pathogenesis. However, increased expression from 4q22, 5q23.2 and 9p21 distinguished SSE from SE and NS and decreased copy number and expression from 2q36-q37 and 6q24 was a specific feature of NS-derived cell lines. Our analysis also highlights 19 regions with both copy number and expression imbalances in greater than 40% of cases. Mining available expression array data identified genes from these regions as candidates for involvement in TGCT development. Supplementary data is available at http://www.crukdmf.icr.ac.uk/array/array.html.
KW - Cell Line, Tumor
KW - Gene Dosage
KW - Gene Expression Profiling
KW - Genome
KW - Humans
KW - Male
KW - Neoplasms, Germ Cell and Embryonal/genetics
KW - Nucleic Acid Hybridization
KW - Testicular Neoplasms/genetics
UR - http://www.scopus.com/inward/record.url?scp=37049028328&partnerID=8YFLogxK
U2 - 10.1038/sj.bjc.6604079
DO - 10.1038/sj.bjc.6604079
M3 - Article
C2 - 18059402
SN - 0007-0920
VL - 97
SP - 1707
EP - 1712
JO - British journal of cancer
JF - British journal of cancer
IS - 12
ER -